| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 988 | 18 | 939 | 84 | 1023 | 193 | 1175 |
| ERLYTX | 91 | 1 | 52 | 3 | 37 | 9 | 55 |
| GI | 192 | 2 | 104 | 14 | 170 | 26 | 158 |
| GU | 438 | 1 | 52 | 28 | 341 | 64 | 390 |
| LEUK | 142 | 4 | 209 | 12 | 146 | 26 | 158 |
| LUNG | 192 | 5 | 261 | 18 | 219 | 34 | 207 |
| LYMPH | 395 | 5 | 261 | 32 | 390 | 62 | 377 |
| MELAN | 277 | 1 | 52 | 2 | 24 | 2 | 12 |
| MMYEL | 159 | 3 | 157 | 4 | 49 | 14 | 85 |
| MULT | 22 | 3 | 157 | 7 | 85 | 14 | 85 |
| OTHER | 38 | 0 | 0 | 1 | 12 | 5 | 30 |
| PREV | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2941 | 43 | 2244 | 205 | 2496 | 449 | 2732 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 115 | 7 | 365 | 14 | 170 | 32 | 195 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 665 | 12 | 626 | 43 | 524 | 98 | 597 |
| LUNG | 304 | 8 | 417 | 34 | 414 | 61 | 371 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 38 | 2 | 104 | 6 | 73 | 12 | 73 |
| PEOLC | 128 | 4 | 209 | 17 | 207 | 33 | 201 |
| PREV | 214 | 5 | 261 | 21 | 256 | 42 | 256 |
| SURV | 19 | 0 | 0 | 3 | 37 | 6 | 37 |
| SXQOL | 575 | 9 | 470 | 47 | 572 | 99 | 603 |
| Total | 2069 | 47 | 2452 | 185 | 2253 | 384 | 2339 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 988 | 18 | 939 | 84 | 1023 | 193 | 1175 |
| CCD | 115 | 7 | 365 | 14 | 170 | 32 | 195 |
| ERLYTX | 101 | 1 | 52 | 3 | 37 | 10 | 61 |
| GI | 192 | 2 | 104 | 14 | 170 | 26 | 158 |
| GU | 438 | 1 | 52 | 28 | 341 | 64 | 390 |
| LEUK | 807 | 16 | 835 | 55 | 670 | 124 | 755 |
| LUNG | 496 | 13 | 678 | 52 | 633 | 95 | 578 |
| LYMPH | 396 | 5 | 261 | 32 | 390 | 62 | 377 |
| MELAN | 277 | 1 | 52 | 2 | 24 | 2 | 12 |
| MMYEL | 159 | 3 | 157 | 4 | 49 | 14 | 85 |
| MULT | 22 | 3 | 157 | 7 | 85 | 14 | 85 |
| OTHER | 76 | 2 | 104 | 7 | 85 | 17 | 103 |
| PEOLC | 128 | 4 | 209 | 17 | 207 | 33 | 201 |
| PREV | 217 | 5 | 261 | 21 | 256 | 42 | 256 |
| SURV | 19 | 0 | 0 | 3 | 37 | 6 | 37 |
| SXQOL | 577 | 9 | 470 | 47 | 572 | 99 | 603 |
| Total | 5010 | 90 | 4696 | 390 | 4749 | 833 | 5071 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 608 | 10 | 522 | 56 | 682 | 122 | 743 |
| ERLYTX | 50 | 1 | 52 | 2 | 24 | 6 | 37 |
| GI | 140 | 2 | 104 | 11 | 134 | 20 | 122 |
| GU | 367 | 1 | 52 | 21 | 256 | 47 | 286 |
| LEUK | 89 | 4 | 209 | 10 | 122 | 17 | 103 |
| LUNG | 122 | 2 | 104 | 7 | 85 | 15 | 91 |
| LYMPH | 252 | 3 | 157 | 24 | 292 | 39 | 237 |
| MELAN | 175 | 1 | 52 | 2 | 24 | 2 | 12 |
| MMYEL | 104 | 3 | 157 | 4 | 49 | 8 | 49 |
| MULT | 8 | 1 | 52 | 2 | 24 | 4 | 24 |
| OTHER | 38 | 0 | 0 | 1 | 12 | 5 | 30 |
| PREV | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1960 | 28 | 1461 | 140 | 1704 | 285 | 1734 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 102 | 6 | 313 | 13 | 158 | 27 | 164 |
| ERLYTX | 10 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 301 | 5 | 261 | 21 | 256 | 45 | 274 |
| LUNG | 187 | 5 | 261 | 21 | 256 | 39 | 237 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 37 | 1 | 52 | 5 | 61 | 11 | 67 |
| PEOLC | 91 | 3 | 157 | 13 | 158 | 27 | 164 |
| PREV | 213 | 4 | 209 | 20 | 244 | 41 | 250 |
| SURV | 19 | 0 | 0 | 3 | 37 | 6 | 37 |
| SXQOL | 387 | 6 | 313 | 29 | 353 | 60 | 365 |
| Total | 1348 | 30 | 1566 | 125 | 1523 | 257 | 1564 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
| BREAST | 791 | 14 | 730 | 64 | 779 | 149 | 907 |
| CCD | 131 | 3 | 157 | 13 | 158 | 32 | 195 |
| ERLYTX | 60 | 1 | 52 | 2 | 24 | 7 | 43 |
| GI | 145 | 2 | 104 | 10 | 122 | 22 | 134 |
| GU | 389 | 3 | 157 | 26 | 317 | 52 | 317 |
| LEUK | 390 | 9 | 470 | 31 | 377 | 62 | 377 |
| LUNG | 310 | 7 | 365 | 27 | 329 | 54 | 329 |
| LYMPH | 253 | 3 | 157 | 24 | 292 | 39 | 237 |
| MELAN | 175 | 1 | 52 | 2 | 24 | 2 | 12 |
| MMYEL | 100 | 3 | 157 | 4 | 49 | 8 | 49 |
| MULT | 22 | 1 | 52 | 2 | 24 | 7 | 43 |
| OTHER | 252 | 4 | 209 | 17 | 207 | 45 | 274 |
| PEOLC | 95 | 2 | 104 | 12 | 146 | 26 | 158 |
| PREV | 216 | 4 | 209 | 20 | 244 | 41 | 250 |
| SURV | 19 | 0 | 0 | 3 | 37 | 6 | 37 |
| SXQOL | 389 | 6 | 313 | 29 | 353 | 60 | 365 |
| Total | 3739 | 63 | 3288 | 286 | 3482 | 612 | 3727 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 836 | 13 | 678 | 66 | 804 | 150 | 913 |
| ERLYTX | 87 | 1 | 52 | 3 | 37 | 9 | 55 |
| GI | 107 | 0 | 0 | 7 | 85 | 15 | 91 |
| GU | 250 | 0 | 0 | 19 | 231 | 43 | 262 |
| LEUK | 108 | 1 | 52 | 7 | 85 | 19 | 116 |
| LUNG | 161 | 5 | 261 | 15 | 183 | 30 | 183 |
| LYMPH | 321 | 5 | 261 | 23 | 280 | 50 | 304 |
| MMYEL | 148 | 3 | 157 | 4 | 49 | 13 | 79 |
| MULT | 22 | 3 | 157 | 7 | 85 | 14 | 85 |
| Total | 2040 | 31 | 1618 | 151 | 1839 | 343 | 2088 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1947 | 29 | 1513 | 166 | 2021 | 329 | 2003 |
| AFFIL | 119 | 4 | 209 | 15 | 183 | 27 | 164 |
| CCOP/NCORP | 1242 | 25 | 1304 | 84 | 1023 | 186 | 1132 |
| Non-SWOG | 1700 | 30 | 1565 | 123 | 1498 | 289 | 1759 |
| Total | 5008 | 88 | 4591 | 388 | 4725 | 831 | 5058 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| MMYEL | S2005 | WM, Prev. Untreated, I/R +/- Venetoclax | 1 | T | 20-NOV-25 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 12 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 10 |
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 10 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 8 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 7 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 6 |
| CCD | S1703 | Met Breast, STM-monitoring v Usual Care | 2 | 4 |
| LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 4 |
| PREV | NRGCC005 | Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs | 1 | 3 |
| LUNG | S1800E | Non-Match: Docetaxel + Ramu +/- Cemiplimab | 1 | 3 |
| MULT | S2101 | Melan or HNSCC, Adv, Cabo + Nivo | 2 | 3 |
| MULT | S2101 | Melan or HNSCC, Adv, Cabo + Nivo | 1 | 3 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 3 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 3 |
| MMYEL | S2209 | MM, Newly Dx, VRd-R->R v DRd-R->R v DRD-DR->D | 1 | 3 |
| CCD | S2417CD | Colrec Surv, Follow-up w/ CTAC site | 1 | 3 |